New workflow integrates the xCELLigence RTCA HT with the BioTek BioSpa 8 Automated Incubator
Clinical studies are expected to start in Q2 2023.
Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial
Becomes the 1st diagnostics company in India to launch BD MAX MDR TB test
IAGES to focus on upskilling and adoption of advanced Minimal Access Surgery technologies in 2023
Themis will market this drug with the brand name REMITHEM.
Investment proposals to the tune of Rs. 54,000 crore has been received in the healthcare and Rs. 17,000 crore has been received in medical education sector
The Survey highlighted that Indian pharmaceutical exports achieved a healthy growth of 24 per cent in FY21 and expressed hope that India’s domestic pharmaceutical market is estimated to grow to US $65 billion by 2024 from estimated US $41 billion in 2021
The WHO has urged China to increase adoption of mRNA vaccines, given their high efficacy against variant strains.
OmiCrisp has been developed with support from Centre for Cellular And Molecular Platforms C-CAMP-InDx Program
Subscribe To Our Newsletter & Stay Updated
